{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:05:05Z","timestamp":1790399105973,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.jdermsci.2004.03.001","type":"journal-article","created":{"date-parts":[[2004,5,13]],"date-time":"2004-05-13T11:04:21Z","timestamp":1084446261000},"page":"43-51","source":"Crossref","is-referenced-by-count":73,"title":["Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis"],"prefix":"10.1016","volume":"35","author":[{"given":"Hidetaka","family":"Fujii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2004.03.001_BIB1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1711660307","article-title":"Sequential dermal microvascular and perivascular changes in the development of scleroderma","volume":"166","author":"Prescott","year":"1992","journal-title":"J. Pathol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0002-9343(90)90425-D","article-title":"Evaluation and management of scleroderma lung disease using bronchoalveolar lavage","volume":"88","author":"Silver","year":"1990","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0889-857X(05)70296-9","article-title":"Immunopathogenesis of systemic sclerosis","volume":"22","author":"White","year":"1996","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2249.1999.00929.x","article-title":"Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1\u03b1 (MIP-1\u03b1) and MIP-1\u03b2) in patients with systemic sclerosis: MCP-1 and MIP-1\u03b1 may be involved in the development of pulmonary fibrosis","volume":"117","author":"Hasegawa","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB5","first-page":"1524","article-title":"Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-\u03b1 are elevated in patients with systemic sclerosis","volume":"30","author":"Furuse","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB6","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/1529-0131(200111)44:11<2665::AID-ART446>3.0.CO;2-S","article-title":"Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis","volume":"44","author":"Distler","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB7","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/1529-0131(200106)44:6<1382::AID-ART231>3.0.CO;2-T","article-title":"Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression","volume":"44","author":"Galindo","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s002960050098","article-title":"Expression of RANTES in biopsies of skin and upper gastrointestinal tract from patients with systemic sclerosis","volume":"19","author":"Distler","year":"1999","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.1681588","article-title":"Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones","volume":"254","author":"Salgame","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB10","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4049\/jimmunol.141.3.849","article-title":"Simultaneous production of IL-2, IL-4, and IFN-\u03b3 by activated human CD4+ and CD8+ T cell clones","volume":"141","author":"Paliard","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB11","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/CMR.9.4.532","article-title":"Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases","volume":"9","author":"Lucey","year":"1996","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0091-6749(97)70030-7","article-title":"Predominance of type 2 cytokine-producing CD4+ and CD8+ cells in patients with atopic dermatitis","volume":"99","author":"Nakazawa","year":"1997","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.187.1.129","article-title":"Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s","volume":"187","author":"Bonecchi","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB14","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0167-5699(98)01346-2","article-title":"Chemokines and chemokine receptors in T-cell priming and Th1\/Th2-mediated responses","volume":"19","author":"Sallusto","year":"1998","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB15","doi-asserted-by":"crossref","unstructured":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma), vol. 23; 1980. p. 581\u201390.","DOI":"10.1002\/art.1780230510"},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB16","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB18","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB19","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/art.1780360815","article-title":"Antihistone antibodies in patients with localized scleroderma","volume":"36","author":"Sato","year":"1993","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/clim.2000.4957","article-title":"CXCR3 and CCR5 ligands in rheumatoid arthritis synovium","volume":"98","author":"Patel","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S","article-title":"Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation","volume":"194","author":"Flier","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1067\/mai.2002.126079","article-title":"Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis","volume":"110","author":"Fujisawa","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB23","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/intimm\/dxf044","article-title":"IFN-\u03b3-inducible expression of thymus and activation-regulated chemokine\/CCL17 and macrophage-derived chemokine\/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis","volume":"14","author":"Horikawa","year":"2001","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.1780350111","article-title":"Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor \u03b1, and interferon-\u03b3 levels in sera from patients with scleroderma [see comments]","volume":"35","author":"Needleman","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB25","first-page":"328","article-title":"Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis","volume":"24","author":"Hasegawa","year":"1997","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB26","first-page":"1751","article-title":"Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis","volume":"151","author":"Mavalia","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB27","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L","article-title":"Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis","volume":"42","author":"Atamas","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB28","first-page":"663","article-title":"Elevated serum tumor necrosis factor-\u03b1 levels in patients with systemic sclerosis: association with pulmonary fibrosis","volume":"24","author":"Hasegawa","year":"1997","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB29","first-page":"2838","article-title":"Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis","volume":"27","author":"Sato","year":"2000","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1034\/j.1399-3003.1999.14b03.x","article-title":"Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies","volume":"14","author":"Majumdar","year":"1999","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB31","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1365-2249.2002.02017.x","article-title":"Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis","volume":"130","author":"Fujii","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1365-2249.2001.01603.x","article-title":"Circulating gamma\/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization","volume":"125","author":"Giacomelli","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB33","first-page":"1252","article-title":"Increased frequency of interleukin 4 producing CD4+ and CD8+ cells in peripheral blood from patients with systemic sclerosis","volume":"28","author":"Tsuji-Yamada","year":"2001","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB34","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1074\/jbc.273.3.1764","article-title":"Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4","volume":"273","author":"Imai","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB35","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1074\/jbc.272.23.15036","article-title":"The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4","volume":"272","author":"Imai","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB36","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1046\/j.1523-1747.2000.00115.x","article-title":"A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin","volume":"115","author":"Vestergaard","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB37","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.4049\/jimmunol.165.4.2205","article-title":"Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells","volume":"165","author":"Sekiya","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB38","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1172\/JCI12655","article-title":"The C\ue5f8C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics","volume":"107","author":"Panina-Bordignon","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB39","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1067\/mai.2003.59","article-title":"Differential expression of thymus- and activation-regulated chemokine (CCL17) and macrophage-derived chemokine (CCL22) by human fibroblasts from cornea, skin, and lung","volume":"111","author":"Fukuda","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB40","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1067\/mai.2001.113524","article-title":"Expression of IFN-\u03b3-inducible protein monocyte chemotactic proteins 1, 3, and 4 and eotaxin in TH1- and TH2-mediated lung diseases","volume":"107","author":"Miotto","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB41","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.4049\/jimmunol.157.10.4602","article-title":"Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production","volume":"157","author":"Chensue","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB42","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0889-857X(05)70297-0","article-title":"Antinuclear antibody in systemic sclerosis (scleroderma)","volume":"22","author":"Okano","year":"1996","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.jdermsci.2004.03.001_BIB43","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/rheumatology\/40.10.1135","article-title":"Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis","volume":"40","author":"Sato","year":"2001","journal-title":"Rheumatol Oxford"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092318110400043X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092318110400043X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T16:57:25Z","timestamp":1682701045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092318110400043X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S092318110400043X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2004.03.001","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}